as embodied and broadly described herein , the present invention is directed to method and devices for the regulation of cell proliferation and gene expression and , in particular , the inhibition of photoaging of the skin , and the revival of necrotic cells . as well , the invention is directed toward a system and method for rejuvenating cells in various stages of necrosis . photoaging of the skin occurs through many mechanisms , including , for example , environmental factors such as tobacco smoke , exposure to the sun , and poor health , to name a few . these events can triggers an inflammatory process in the skin and the associated cellular mechanisms . there is also a more chronic low - level type of injury that does not produce a sunburn reaction , but which produces the changes of chronic photoaging . chronological aging of the skin and photoaging and other environmentally induced changes share many or in some cases , all of the same pathways as uv induced photoaging of the skin . these pathways involve up and / or down regulation of cell proliferation and also alterations in the level of expression of many different types of genes . it was surprisingly discovered that , this combination of regulation of cell proliferation and regulation of gene expression , is responsible for photoaging of the skin and other cells and tissues , and thus , photoaging could be reversed or at least ameliorated by affecting these same processes . accordingly , one embodiment of the invention is directed to identifying and correlating the phenotypic and genotypic expression characteristics of photoaging and other skin and cell - associated disorders . once identified , correlated maps can be compiled and collected into a data base to allow for the rapid and efficient identification of similar disorders and conditions for the purpose of tailoring appropriate treatment . further , once identified , treatment and appropriate intervention and prevention methods can be used to halt or even reverse the appearance and genotypic characteristics of photoaging . thus , the invention is not directed to artificially hiding or covering up aspects associated with aging , but actually reversing the processes and mechanisms associated with aging - related phenomena . a further embodiment of the invention is directed to applying these same mechanisms and tools to other cells such as stem cells ( completely undifferentiated cells ) and progenitor cells ( partially differentiated cells ). by altering the cell cycle , cell proliferation , and / or gene expression characteristics of these cells along defined parameters , it is possible to determine differentiation pathways and to create or recreate cells , tissues and other cell structures for disease therapy and prevention , and wound healing . methods to modulate cell proliferation and gene expression include exposure to electromagnetic radiation in an amount or dose that is sufficient to stimulate the desired effect ( e . g . see u . s . pat . nos . 6 , 398 , 753 , 5 , 837 , 224 , and 6 , 130 , 254 ; and u . s . patent application nos . 2002 / 0028185 , 2001 / 0053347 , 2003 / 0004556 , 2003 / 0004499 , and 2002 / 0123746 , all of which are specifically and entirely incorporated by reference ). for example , exposure of skin to led can stimulate or inhibit the expression of various gene products . these same methods can be used to cause stimulation or inhibition of cell proliferation and cell cycle modulation in these cell populations . further , photomodulation can be used in combination with certain oral agents ( for systemic affects ) or topical agents ( for localized affects ) ( e . g . vitamin a , retin a , retinol ), for a desired effect unachievable with either stimulant used individually . the types of cells that can be affected include , but are not limited to skin cells ( reversal of photoaging ), nerve cells ( disease prevention and treatment ), stem cells ( tissue reconstruction ), cells of hair follicles ( hair growth or inhibition ), cells of the immune system including cells intimately involved with the process of inflammation ( due to disease , infection , or congenital disorder ), wound repair , and combinations thereof . modulation can be achieved by exposing cells to electromagnetic radiation ( e . g . photomodulation ) such as , preferably , visible light , ( e . g . purple , blue , green , yellow , orange , red ), infrared radiation , ultraviolet light ( uva , uvb , uvai , uva2 , or combinations thereof ), or combinations of any . preferred exposure strengths and exposure times are as set forth in the attachments hereto , but may include pulsed exposures , continuous and periodic exposures . ultraviolet light injury triggers reactive oxygen species and a series of cell signaling events called kinase cascades . one of the final common pathway in the up and down regulation of fibroblast activity is through ap - 1 which up regulates and increases the production of various mmp &# 39 ; s including mmp 1 ( collagenase 1 or interstitial collagenase synthesis ), mmp 9 ( gelatinases b ) and mmp 3 ( stromelysins 1 ). the production of these mmp enzymes results in the breakdown of collagen , elastin and ecm in the dermis of the skin . simultaneously the actual production of collagen i and other structural proteins may be diminished or down regulated thus further accelerating the process . the aging of living cells , tissues and organs may be related to free radical exposure and oxidative stress . to apply this model to aging skin , chronological aging results from a decrease antioxidant defense mechanisms while uv photoaging and other environmental stresses can be thought of as increasing oxidative stress . the net result of decreased antioxidant defense or increased oxidative stress is increase production of ( ros ) or free radicals . increased ros production in the skin stimulates cell signaling or signals transduction pathways , which produce altered gene activity . damage to structural proteins ( e . g . damage , disruption and fragmentation of collagen caused by uv light ) alters proteins , structure and function which in turn changes cell signaling and may alter gene activity . another possible outcome of increased ros production is the production of dna mutations , which then alters gene structure and thus may alter the normal structure and function of cells . much of the variation in the human state , as far as disease and response to environmental insults may be mediated by relatively small differences in the genetic make - up from one individual to the next . single nucleotide polymorphisms ( snps ) are currently being very actively investigated as a means of identifying and potentially predicting the differences in biological responses of humans and other animals . for example , characterization of snps may allow prediction of whether a patient is more or less likely to develop a specific disease or tumor and thus take known preventative measures . another possible application is the use of snps to screen individuals before placing them on a prescription drug to identify those individuals who might be more likely to develop serious side effects and thus avoid the use of that drug . another potential novel use of snps is to identify the haplotype or patterns of snps , which are associate with , for example , chronological aging of the skin . some individuals and families have reduced risk of skin cancers or simply look younger than their peers of the same age group and like backgrounds . a profile of snps can be developed that characterizes common factors associated with the phenotypic changes of aging skin ( defined the snp genotypic pattern that puts an individual at a greater risk of accelerate aging from increased oxidative stress from environmental agents ). this allows for a treatment plan , which would have greater anti - aging benefits . tgf - b is a major cytokine for cell signaling and inhibits the growth of epidermal keratinocytes and stimulates the growth of thermal fibroblasts . it also induces synthesis and secretion of the major collagen elastin and inhibits the expression of mmp 1 and mmp 3 . there are multiple tgf - b &# 39 ; s , tgf - b 1 , tbr i , tbr ii , many of which are down regulated in aging skin cells . tgf - b is also activity altered in aging skin by binding with decerin and when this combines with collagen affects the tinsel strength of skin as well as controlling the rate of collagen fiber formation . c jun mrna is doubled in activity and age human skin compared to young skin but c - fos was unchanged . mmp 2 is not regulated through ap 1 . erk activity is reduced in aging skin , but jnk activity is increased 3 - 4 times in aging skin . environmental insults - damage can vary anatomically over a person &# 39 ; s body . these methods allow for rejuvenating human skin including the steps of simultaneously preventing collagen degradation while also stimulating the formation of new collagen in aging human skin . increased mmp &# 39 ; s result in reduced levels of erk , cyclin d2 and type i and iii pro collagen . this is part of the core genotype , phenotype stimulating a number of keratinocytes as well as decreasing c - gen activity and increasing erk activity . a system of sunscreens , topical oil and antioxidants , topical oil and photomodulated ecm stimulation and mmp and mmp inhibition and various combinations and mixtures of the above . inhibiting c - gen formation also inhibits formation ap - i and thus diminishes mmp &# 39 ; s , inducing the proliferation of keratinocytes and fibroblasts . mitochondria and atp production mechanisms ( e . g . cytochrome expression ) can be modulated by electromagnetic radiation . led light activates cell surface receptors via redox mediated in activation or a receptor type protein tyrosine phosphatase ( rtpt ). sap ( stress activated pathways ) verses mitogen activated pathways compare and contrast sap increase mmp and decreases pro collagen 1 and 2 if c jun goes up . primarily has to do with the ecm production whereas the map pathways activate erk induced cyclins and promote cell growth so that psat &# 39 ; s tend to increase or decrease protein production whereas the maps increase or decrease cell growth . ras / map / ap - 1 pathway plays a key role in response to wounding . fgfr1 contains sites in the promoter region and il1 antagonist promoter . antioxidant compounds also have anti - erythema sunscreen effect although they may not inhibit the increased mmp after uv exposure , lycopene is one of these . led photomodulation can also be used to diminish sunburn activity and mmp levels were maxed about 24 hours later . use a solar simulator to cause a one med minimal erythema dose on the arm in two places on volunteers and treat one a couple times a day with the gw device and to reduce redness with the chromometer . biopsy will show what happens when you treat them with gw after uv . inhibiting cytocrome p - 450 breakdown of retinoids increases retinoid strength concentration . while not wishing to be constrained to a particular theory of operation , the invention includes the surprising discovery that multiple receptor - mediated pathways may be photomodulated in human or mammalian skin that lead to an expression of the genotype associated with a younger or more youthful or less aged skin both in appearance and structurally and functionally . reference to infrared - a radiation induced mmp 1 . infrared is capable of producing mmp 1 by way of up regulation or activation of mapk signaling pathway that is the activation of erk ½ that the promoter region of the mmp 1 gene was activated by ira without the production of heat , but that timp 1 was not increased . mmp - 8 or elastase is increased with inflammatory reaction , which also involves ap i . and when nf - kb is increased it activates more of il - 1 and tnfa that discontinues the presence of continued inflammation . fibroblasts sensor matrix surround them and when in contact with a matrix they tend to be less active produce little collagen , but when the presence of collagen breaks down products such as gelatin , they tend to produce more collagen if the inflammation persists . the collagen not only proliferates , but produces less scarring . topical compounds that inhibit cytokines are indirect mmp inhibitors because if they block the pathway the signals mmp the essentially block this . the same is true for mmp regulation . regarding nutraceuticals , vitamin c can be topically applied to assemble stable collagen molecules . collagen i and collagen iii can be stimulated by topical of vitamin c , whereas elastin , fibrilin ½ are not affected nor is mmp 1 , 2 , and 9 affected . timp was increased , timp 2 was unchanged . proteolytic degradation of ecm is an essential feature of repair and remodeling during continuous wound healing . wound repair consists of narcotic or damaged tissue , cell and / or tissue migration , angiogenisis , remodeling of newly synthesized ecm , and cell growth factor regulations . during wound repair mmp 1 and mmp 3 increase as well as mmp 2 and 9 . mmp 13 , in particular , for chronic wounds , but also acute . timp is also altered . mmp 1 , 3 , 9 are increased with uvb ; increased elastin and fibrilian verscian ; result in the formation of non functional elastin fibers and reduce skin elasticity and aging or photoaged skin . collagen i is reduced , and uva shows increased expression of mmp 1 , 2 , 3 . disease states - systemic sclaraderma skin fibroblasts produced less mmp 1 and mmp 3 and more timp 1 compared to normal . skin cancers bcc produce more mmp 1 , 2 , 9 and 11 . more signs of photoaging , bruising , skin hypopigmented areas , fibrosis . methods and inventions for preventing the photoaging or chronological or environmental aging of unaged skin include retinoids that retard the effects of photoaging topical antioxidants to reduce presence of ros in the skin . environmental stresses include oxidants , heat , uv light . thus , led phototherapy is both an ecm protein / collagen stimulator , and an mmp inhibitor . dose dependent uvb induction of ap 1 and nf - kb , these induced mmp 2 and mmp 9 . the formation of collagen bundles is responsible for the strength , resiliency and elasticity of the skin . in one embodiment of the invention single or multiple light sources may be used , to produce either a single dominant emissive wavelength , i . e ., a narrowband multichromatic radiation , or multiple wavelengths ( either monochromatic , narrowband multichromatic , wideband multichromatic , or combinations thereof ). the single or multiple combinations may be applied either simultaneously or sequentially . for example a device emitting narrowband , multichromatic electromagnetic radiation with a dominant emissive wavelength of about 590 nm (+/− about 10 nm ) and also some light in the 850 nm range and , optionally , a small amount in the 1060 nm range . it has been discovered that the combination of the visible 590 and the infrared 850 nm is bioactive . a special ir filter may also be added to reduce the ir component of the radiation that the target skin or tissue is exposed to , as this is believed to unsymmetrically dampen the shape of the ir / 850 curve . treatment examples of such a device are shown in the attached drawing figures and illustrate that at 850 nm , there is believed to be a ‘ dose dependent ’ effect on fibroblasts . further , at a power level of about 1 mw / cm 2 , photomodulation occurs for anti aging phenotype effect ( those skilled in the art will recognize that power meters cannot measure this precisely , so there may be some variation / error in meter methods ). generally , where a treatment that does not cause thermal injury is desired , an energy fluence of less than about 4 j / cm 2 is preferable . the ratio of yellow light to ir radiation in the radiation used for treatment has been found to have an effect on the overall performance of the present system . relative amounts of each type of radiation are believed to be important , more so than the actual radiation level ( provided that ablation does not occur ). at about 4 mw / cm 2 for 590 nm and about 1 mw / cm 2 for the 850 nm ( i . e ., a 4 : 1 ratio of yellow to ir ) has been found to produce good results . mother factor to consider is the shape of the amplitude vs . wavelength curve for the ir component of the system . the ‘ code ’ refers to the pulse scheme for various treatment regimen . this includes various factors such as pulse length , interpulse delay , and pulse repetition . for example a treatment may comprise a pulse code of 250 msec “ on ” time , 100 msec “ off ’ time ( or dark period ), and 100 pulses . this produces a total energy fluence , in j / cm2 , of 25 seconds times the power output level of the emitters . this permits a comparison of pulsed versus continuous wave treatment ( the “ code ” for continuous wave treatment would be 1 pulse , an “ on ” time of whatever the treatment length is chosen to be , and an “ off ’ time of 0 sec .) examples showing various codes , ratios , and power levels and the resulting effect on the photoaging effect on certain genes , and other data , are shown in the attached data tables and drawing figures . the present invention is also related to a method and apparatus for treating sunburn and other sun - related photoeffects on human or mammalian skin . one approach is to use retin a for prior to sun exposure and research is being conducted using vitamins c , e , and other antioxidants topically . another approach being tried is the use of the antioxidant lycopene , administered orally , to quench some of inflammation from sunburn . the present invention shows great improvement of such treatment methods , however . one may think of wrinkles , sun damage , and other sun - related photo effects as ‘ solar scars ’. they are cumulative injuries that result from repeated or long - term exposure to the sun . the human body employs and imperfect wound repair mechanism , thus the solar simulator of the present invention is , in some ways , a model for other wound healings . the present invention employs a treatment that simulates sunlight broken down into its component parts . the uva 1 portion is used in some embodiments , but there is uvb and combinations of uva and uvr that are more oncogenic . for example , uv , and in particular uva 1 , causes skin sagging and photoaging , changes to the dermal matrix and structural proteins , and upregulates mmps . uv radiation also causes the upregulation of inflammatory pathways such as il1 , il6 and nfkb . these pathways are known to affect aging and other sun - related skin disorders and environmental damage , such as smoking , pollution , drugs , diseases , thermal injuries , other wounds . the present invention is believed to inhibit or reverse the effects of photoaging and other skin disorders by reversing the direction of gene up / down regulation from the unfavorable and destructive directions caused by the effects of the solar simulator uva1 for things like collagen , mmp1 , cjun which is important related to mmp1 , il / interleukins in inflammatory pathway , and cytochromes . the attached examples describe the use of the present system for illustrative treatments . the systems and methods of the present invention may be used in combination with various wound dressings like bandage strips modified to have a transparent covering , so that the desired spectra of photomodulation by led or other light is transmitted to the wounded area of the skin or target tissue . one embodiment includes ‘ trap door ’ to permit the periodic inhibition of light transmission . the opening or translucent / transparent portion of the bandage may comprise an ir filter , as well . in instances where it is undesirable to include an opening as part of the bandage or wound dressing , the size of led &# 39 ; s and other light sources makes it possible to include a light source within the bandage . such a source could be powered from a small battery and include means for having the light source automatically or manually apply treatment at regular intervals and according to a variety of preset codes ( for example , a dressed chemical burn may require a different code than a cut or electrical burn ). as well , various topical compositions for enhancing the penetration of the light through the skin or target tissue can be included in the dressing or bandage or applied to the skin or target tissue prior to covering the affected skin with the bandage or dressing . a light source within the bandage may also be coded to ‘ release ’ or to ‘ activate ’ substances or delivery vehicles for substances so that oxygen , antibacterial , antiviral , anti fungal , etc ., or other agents released . combinations of such compositions may be used as well . another application would allow for the treatment of blood outside of the body ( extracorporeally , in a phoresis device for example ). the blood may be run through banks of arrays of led , or other light or emr , and then photomodulated either directly or by an agent that was photoactivatable , or both , to stimulate the immune system , treat disease , etc . the present system and method may also be used for retinal and other eye treatments , alone or along with antioxidant eyedrop - type medications , bioengineered peptides , and growth factors . antioxidant eyedrops include , but are not limited to glutathione , vitamin c , vitamin e , catalase , ubiquinone , idebenone , etc . other applications of the present invention include nerve regeneration , hormone manipulation ( thyroid disease is common and is particularly contemplated due to the proximity of the thyroid to the skin ). as well , photomodulating adipocytes for fat reduction , cellulite , etc . may be accomplished using light sources in the range of about 850 - 950 nm and 1000 - 1100 nm . the following examples illustrate embodiments of the invention , but should not be viewed as limiting the scope of the invention . attached hereto are graphs , tables of data , and examples that further illustrate the various embodiments of the invention , as well as lists of gene products which can be regulated by methods of the invention . in the appendix , the results of two experiments which illustrate the invention are shown . other embodiments and uses of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein . all references cited herein , including all publications , u . s . and foreign patents and patent applications , are specifically and entirely incorporated by reference . it is intended that the specification and examples be considered exemplary only .
a method including photomodulating mammalian tissue with more than one light source of narrowband , multi chromatic electromagnetic radiation , wherein at least one light source emits radiation at a wavelength corresponding to yellow light and at least one light source emits radiation corresponding to infra - red light , wherein the ratio of the intensity of yellow light to infra - red light is about 4 : 1 .